|
0
|
|
A two-stage diagnostic model for discriminating and assessing risk of meropenem heteroresistance in Pseudomonas aeruginosa.
(academic.oup.com)
|
Fan Y
…
Chen Y
Journal of Antimicrobial Chemotherapy
2026-02-02
|
#modeling
#infection
#amr
#diagnostics
|
|
0
|
|
Cooperation between HIV-1 integrase natural polymorphism K156N and 3'PPT mutations in dolutegravir monotherapy failure.
(academic.oup.com)
|
van Osch JAT
…
Mesplede T
Journal of Antimicrobial Chemotherapy
2026-02-02
|
#modeling
#amr
#mutation
#hiv
#integrase
|
|
0
|
|
Development of a risk prediction model for vancomycin-associated acute kidney injury: a multicentre retrospective study.
(academic.oup.com)
|
Ishigo T
…
Matsumoto K
Journal of Antimicrobial Chemotherapy
2026-02-02
|
#pharmacokinetics
#modeling
#antibiotic
#nephrotoxicity
#aki
|
|
0
|
|
Pharmacokinetics of cefotaxime and its metabolite desacetyl-cefotaxime to optimize dosing in critically ill children and children with sickle cell disease.
(academic.oup.com)
|
Abdalla S
…
Hirt D
Journal of Antimicrobial Chemotherapy
2026-02-02
|
#pharmacokinetics
#modeling
#dosing
#pediatric
|
|
0
|
|
Effects of extracorporeal membrane oxygenation on the pharmacokinetics and tissue penetration rates of vancomycin and linezolid: data from Landrace pigs.
(academic.oup.com)
|
Zhang H
…
Wang R
Journal of Antimicrobial Chemotherapy
2026-02-02
|
#pharmacokinetics
#modeling
#infection
#amr
|
|
0
|
|
Physiologically based pharmacokinetic modelling to optimize dosing regimen of biapenem in renal impairment and elderly populations.
(academic.oup.com)
|
Li W
…
Dong J
Journal of Antimicrobial Chemotherapy
2026-02-02
|
#pharmacokinetics
#modeling
#dosing
#renal impairment
|